Filter
373
Text search:
Pharmacology
Featured
Recommendations
34
New Publications
79
Language
Document type
No document type
192
Studies & Reports
73
Guidelines
68
Manuals
17
Training Material
7
Situation Updates
4
Fact sheets
4
Strategic & Response Plan
3
Resource Platforms
2
Online Courses
2
Brochures
1
Countries / Regions
India
32
South Africa
14
Ethiopia
10
Global
9
Africa
8
Nigeria
7
Nepal
6
Kenya
5
Rwanda
5
Bangladesh
5
Western and Central Europe
5
Russia
5
Uganda
4
Syria
4
Brazil
4
Latin America and the Carribbean
4
Sierra Leone
3
Ghana
3
Mozambique
3
Namibia
3
Eswatini/ Swaziland
3
Ukraine
3
Angola
3
Lesotho
3
Myanmar / Burma
3
Burkina Faso
2
Liberia
2
Congo, Democratic Republic of
2
Guinea-Bissau
2
USA
2
Zimbabwe
2
Germany
2
Zambia
2
Tanzania
2
Indonesia
2
Malawi
2
Argentina
2
Botswana
2
Eastern Europe
2
Haiti
1
Philippines
1
South Sudan
1
Iraq
1
Thailand
1
China
1
Sudan
1
Ecuador
1
Bolivia
1
East and Southern Africa
1
Paraguay
1
Asia
1
Mongolia
1
Southern Africa
1
Canada
1
Tajikistan
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
126
Clinical Guidelines
42
Public Health
17
Women & Child Health
8
Pharmacy & Technologies
7
Capacity Building
3
Key Resources
1
Toolboxes
Pharmacy
51
Mental Health
45
AMR
33
TB
25
HIV
24
COVID-19
21
Caregiver
12
NTDs
12
NCDs
12
Conflict
7
Specific Hazards
5
Ebola
4
Disability
3
Planetary Health
3
Natural Hazards
2
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
Downloaded from https://aidsinfo.nih.gov/guidelines on 11/27/2019
Visit the AIDSinfo website to access the most up-to-date guideline.
Register for e-mail notification of guideline updates at https://aidsinfo.nih.gov/e-news.
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect
...
Guidelines for the Prevention and Containment of Antimicrobial Resistance in South African Hospitals
These guidelines form part of efforts to institutionalise the prevention and containment of antimicrobial resistance (AMR) in health care facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two inte
...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t
...
Effectiveness of Education and an Antibiotic-Control Program in a Tertiary Care Hospital in Thailand
Overuse of antimicrobial agents occurs globally in both community and hospital settings. Misuse of antibiotics can lead to a variety of adverse outcomes, including the development of antimicrobial resistanceand increased cost of hospitalization. This issuehas been particularly problematic in de
...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate
...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p
...
In line with its decentralization principle, the Ethiopian Health Policy has achieved great progress in improving access to comprehensive HIV/AIDS services to the majority of the population. Both quality and coverage of services have improved significantlysince the initiation
...
Volumen 5 / Número 1 , 1025-1028 • http://www.revistabionatura.com
To describe the behavior of Tuberculosis/Human Immunodeficiency Virus co-infection in a cohort of people affected by sensitive Tuberculosis in Ecuador from 01 January 2010 to 31 December 2015. Results: The percentage of co
...
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis
...
Guidelines for the Prevention and Contaiment of of Antimicrobial Resistance in South African Hospitals
recommended
These guidelines form part of efforts to institutionalize the prevention and containment of antimicrobial resistance (AMR) in healthcare facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two interr
...
Lancet Public Health 2022 Published Online April 6, 2022 https://doi.org/10.1016/S2468-2667(22)00087-1
Curr Opin Pharmacol . 2022 Apr;63:102203.doi: 10.1016/j.coph.2022.102203. Epub 2022 Feb 11.
The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean (CA). This region, which has a high prevalence of chronic diseases, has been one of the most affected
...
The guideline on Drug misuse: opioid detoxification, commissioned by NICE and developed by the National Collaborating Centre for Mental Health, sets out clear, evidence-based recommendations for healthcare staff on how to work with people who misuse opioids to significantly improve their treatment a
...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE
...
